CEO Michael Pellini, MD, calls the transformational billion-dollar-plus deal his company, Foundation Medicine Inc., inked with Roche in January 2015, “an opportunity to both broaden the existing business and, for the first time, think about incorporating additional assets.”
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?